Delivery Order SPE2DR25D3005-SPE2DR26FP7YK
- Not listed
- The Defense Logistics Agency awarded a $1,702.92 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for OPZELURA 1.5% Cream in 60-gram quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 4, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,673.29 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in 60-gram quantities on July 21, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, carries no set-aside designation and represents a competitively awarded contract. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,620.90 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60GM) on August 12, 2025, with completion expected by August 13, 2025. This is a firm fixed-price, non-competitive delivery order under the company's existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,760.29 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60gm), a topical pharmaceutical product. This firm fixed-price, non-set-aside contract was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,875.38 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60GM) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,174.81 for OPZELURA 1.5% Cream (60gm), a topical pharmaceutical product. This firm fixed-price contract, awarded on July 24, 2025, with completion scheduled for July 25, 2025, carries no set-aside designation and represents a competitively awarded procurement. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $9,046.93 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in 60-gram quantities on November 18, 2025, with completion scheduled for November 19, 2025. This firm fixed-price contract represents a non-competitive set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate headquarters location in...
- The Defense Logistics Agency awarded a $16,474.15 delivery order to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in 60-gram units under a firm fixed-price contract. This non-set-aside delivery order was competitively awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $3,430.79 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream 60GM on December 2, 2025, with an ultimate completion date of December 3, 2025. This firm fixed price contract represents a non-set-aside, competitively awarded procurement under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,650.79 on September 15, 2025, for OPZELURA 1.5% Cream in 60-gram quantities, with final delivery scheduled by September 16, 2025. This non-competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement under the company's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP7YKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $20,430.33 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in 60-gram units. This firm fixed price contract, awarded December 10, 2025, with completion scheduled for December 11, 2025, represents a non-competitive delivery order against the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's $999,999,999.00 Pharmaceutical Prime Vendor Global IDC with DLA Troop Support Medical (contract number SPE2DX), which runs through December 2026 and serves as a comprehensive vehicle for supplying pharmaceutical products and medical supplies to military healthcare systems worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, holds significant federal contracting capacity and regularly fulfills medical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. As a global pharmaceutical support contractor, the company's IDC enables flexible fulfillment of diverse medication needs across multiple therapeutic domains to support military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.4k | 12/9/25 |